|
|
|
|
| CHROMABOND® Drug |
|
| special silica phase for SPE enrichment of drugs from urine or plasma |
|
| Features |
|
 |
base material silica, pore size 60 Å, particle size 45 µm, specific surface 500 m2/g, pH stability 2 – 8
special bifunctional modification - C8 / SA (strong cation exchanger - benzenesulphonic acid) |
|
recommended application:
enrichment of acidic, neutral and basic drugs from urine or plasma (e.g. application 302020) |
Ordering information
| |
|
Volume |
Adsorbent weight |
Pack of |
| |
 |
CHROMABOND® Drug polypropylene columns |
| |
|
100 mg |
200 mg |
500 mg |
|
|
| |
1 mL |
730681 |
|
|
|
100 |
| |
3 mL |
|
730168 |
730684 |
|
50 |
| |
6 mL |
|
|
730682 |
|
30 |
| |
CHROMABOND® Drug polypropylene columns · BIGpack |
| |
|
|
200 mg |
|
|
|
| |
1 mL |
|
730168.250 |
|
|
250 |
| |
 |
CHROMABOND® LV-Drug |
| |
|
|
200 mg |
|
|
|
| |
15 mL |
|
732168 |
|
|
30 |
| |
 |
CHROMABOND® MULTI 96 Drug |
| |
|
|
|
|
96 x 100 mg |
|
| |
|
|
|
|
738161.100M |
1 |
| |
|
|
|
|
|
|
|
|
 |
|
|
 |